Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(4.44)
# 300
Out of 5,127 analysts
20
Total ratings
52.63%
Success rate
39.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $37 | $22.70 | +63.00% | 2 | Feb 3, 2026 | |
| GPCR Structure Therapeutics | Maintains: Buy | $60 → $90 | $78.55 | +14.58% | 2 | Dec 19, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $35 → $50 | $32.44 | +54.13% | 1 | Dec 15, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $46 → $60 | $17.13 | +250.26% | 2 | Dec 8, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $50 → $60 | $48.37 | +24.04% | 4 | Dec 3, 2025 | |
| PEPG PepGen | Maintains: Buy | $18 → $20 | $5.51 | +262.98% | 3 | Nov 13, 2025 | |
| RNA Avidity Biosciences | Downgrades: Neutral | $87 → $72 | $72.89 | -1.22% | 2 | Oct 27, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $6.29 | +281.56% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $0.72 | +2,676.62% | 1 | Sep 30, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $5.61 | +149.55% | 1 | Aug 15, 2025 |
ACADIA Pharmaceuticals
Feb 3, 2026
Reiterates: Buy
Price Target: $37
Current: $22.70
Upside: +63.00%
Structure Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $60 → $90
Current: $78.55
Upside: +14.58%
Stoke Therapeutics
Dec 15, 2025
Maintains: Buy
Price Target: $35 → $50
Current: $32.44
Upside: +54.13%
Dyne Therapeutics
Dec 8, 2025
Maintains: Buy
Price Target: $46 → $60
Current: $17.13
Upside: +250.26%
Maze Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $50 → $60
Current: $48.37
Upside: +24.04%
PepGen
Nov 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $5.51
Upside: +262.98%
Avidity Biosciences
Oct 27, 2025
Downgrades: Neutral
Price Target: $87 → $72
Current: $72.89
Upside: -1.22%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $6.29
Upside: +281.56%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $0.72
Upside: +2,676.62%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $5.61
Upside: +149.55%